Market Tracker

02/20 5:31am ET

Endocyte Inc (NASDAQ:ECYT)

2.22
Delayed Data
As of Feb 17
 -0.02 / -0.89%
Today’s Change
1.98
Today|||52-Week Range
4.33
-12.94%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close2.24
Today’s open2.24
Day’s range2.11 - 2.28
Volume138,225
Average volume (3 months)202,724
Market cap$93.8M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-3.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.54

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...+0.00+0.16%
EIGREiger BioPharmaceuti...+0.15+1.34%
CPIXCumberland Pharmaceu...-0.02-0.35%
CPRXCatalyst Pharmaceuti...+0.03+2.68%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts